Three Recombinant Protein Products for Global Licensing
Views: 72 Author: Unibest Publish Time: 2025-02-06 Origin: Site
Unibest is proud to partner with a renowned Chinese Pharmaceutical company and announce the following global licensing opportunities:
Oprelvekin
The product is formulated as a small-volume lyophilized powder injection and was launched in 2008. It is primarily used to treat thrombocytopenia caused by radiotherapy and chemotherapy in cancer patients, with demonstrated significant advantages compared to both domestic and international products. The research achievement has reached international advanced standards. As an innovative drug with independent intellectual property rights, national invention patent, and National Class 1 New Drug Certificate, its successful launch filled a gap in the domestic market.
The product is formulated as a small-volume lyophilized powder injection, launched in 2007 as the first third-generation thrombolytic drug in China. It is primarily used for treating acute myocardial infarction, significantly reducing the total burden of post-infarction transient ischemia, lowering both early and late mortality rates, and promoting patient recovery. It is also used for cerebral infarction, pulmonary embolism, and deep vein thrombosis.
Our epoetin alfa is a National Class 2 New Drug launched in 1998 and is formulated as a small-volume injection. It primarily treats anemia caused by renal insufficiency in both dialysis and non-dialysis patients, and supports perioperative red blood cell mobilization in surgery. The product shows excellent tolerability with efficacy and safety comparable to imported alternatives. This product was included in the "Ninth Five-Year" National Science and Technology Tackling Plan and was recognized among Shandong Province's "Top 10" High-Tech Products and Innovation Plan projects. Having achieved internationally advanced and domestically leading standards, it is available in six specifications: 2000IU/1ml/vial, 3000IU/1ml/vial, 4000IU/1ml/vial, 5000IU/1ml/vial, 9000IU/1ml/vial, and 12000IU/1ml/vial.
